Ecs Botanics Holdings Ltd · ASX:ECS
Ecs Botanics — Tip Conference (October 2026)
14 slides from Ecs Botanics's conference presentation, Oct 21, 2026
Slide 1: ECS Botanics Holdings Ltd
rsonal use only ECS Botanics Holdings Ltd An Australian medicinal cannabis cultivator and manufacturer ASX : ECS Nan-Maree Schoerie OCTOBER 2026 CEO and Managing Director
Slide 2: Disclaimer
Disclaimer rsonal use only This presentation has been prepared by ECS Botanics recommendation in relation to the purchase or sales of contractors or agents about the accuracy, completeness Holdings Limited (“Company”). shares or other securities in any jurisdiction. or fairness of any information or
Slide 3: Capital Structure
Capital Structure Market capitalisation Share price Managing Director ownership Top 20 ownership rsonal use only $8.0m $0.005 6.4% 43% II N N V V E As at 16 Oct 2026 As at 16 Oct 2026 As at 16 Oct 2026 As at 16 Oct 2026 E S S T T O Available Funding Cash/Drawn Debt O R Shares on issue Listed options
Slide 4: Corporate History
Corporate History Australian Medicinal Cannabis Cultivator and Manufacturer rsonal use only I N V E S T O R ECS Botanics established in Tasmania in 2018 and listed on the ASX in 2019 Acquired Murray Meds, located in NW Victoria, a GMP licensed facility in March 2021 Low-cost production model a
Slide 5: Accelerating Global Medical Cannabis Market
Accelerating Global Medical Cannabis Market Forecast Growth: AUD $65B in 2025 → AUD $147B by 2030, a CAGR ~ 18% rsonal use only I N V E S T O R Europe and UK $2.5b AUD P R E S E N T A T I O N Aus $1b AUD Adult Use Medical Only 5 https://cannabusinessplans.com/cannabis-legalization-map/
Slide 6: Demand Driven by Unmet Needs
Demand Driven by Unmet Needs rsonal use only • Initial legalisation was driven by the I N V E S T O R incredible benefits of medical cannabis for intractable childhood epilepsy P R E S E N T A T I O N • The global medicinal cannabis market is witnessing rapid expansion, driven by accelerating legali
Slide 7: People, Process and Products
People, Process and Products ECS has identified most successful genetics, built a strong bench and launched broad range of own brand products rsonal use only I N V E S T O R P R E S E N T A T I O N GROW MANUFACTURE BRAND & DISTRIBUTE Low-cost Australian eu-GMP manufacturing Higher-value own-brand sa
Slide 8: A growing portfolio across value, differentiated and premium products
A growing portfolio across value, differentiated and premium products rsonal use only I N V E S T O R P R E S E N T A T I O N OzSun AVANI Portfolio expansion Value-led Australian-grown range of Differentiated finished-dose products Premium brands and new formats flower and pastilles +35.7% Terphog
Slide 9: ECS is an established Australian platform delivering results
ECS is an established Australian platform delivering results rsonal use only Quarterly sales Cash generation $5.49m 5 quarters ▲ 13.1% QoQ Consecutive positive operating cash flow Quarterly B2C sales FY26 Revenue $3.91m $21.4m 44.5% YoY sales growth ▲ 10% YoY FY26 EBITDA Market momentum ▲ 11.9% QoQ
Slide 10: Increasing productivity leveraging experienced team
Increasing productivity leveraging experienced team rsonal use only Operational FY26 outdoor FY26 PCE Production cost per cultivation trimmed flower production gram infrastructure 3.1 tonnes 5.3 tonnes Reduced 26 PCEs ▼ 33% - PCE Protective cropping ▲ 12% YoY ▲ 43% YoY ▼ 44% - outdoor enclosures 10
Slide 11: Four international pathways provide the next leg of commercial growth
Four international pathways provide the next leg of commercial growth rsonal use only I N V E S T O R UK – Curaleaf Germany – established Poland - Koyi New Zealand – market entry finished-dose exports Six ECS-branded P R E S E N T A T I O N Australian-grown flower OzSun launched June First flo
Slide 12: Unique IP
Unique IP AVANI Advanced capsules have a patented delivery Terphogz® are an award-winning Californian genetics system, VESIsorb ®. Clinically proven in human trials to producer. ECS has an 8-year exclusive licence rsonal use only increase absorption of cannabidiol by 4x and 3x faster. agreement
Slide 13: Next proof points are commercial
Next proof points are commercial Continue to take market share with Australian grown flower and recently Grow Australian brands introduced product formats such as All in One Vapes and Terphogz® flower rsonal use only Expand selected branded formats I N V E S T O R Convert international pathway
Slide 14: Contact Us
E C S B O T A N I C S H O L D I N G S L T D Contact Us rsonal use only Call us today at 1300 833 988 Email us at info@ecs-botanics.com For investor and media enquiries: Tim Dohrmann tim@nwrcommunications.com.au VISIT US 14
ECS Botanics Holdings — Tip Conference (October 2026) on 6ix